136 related articles for article (PubMed ID: 19479144)
1. Cutaneous lichenoid eruption caused by imatinib mesylate in a Japanese patient with chronic myeloid leukaemia.
Kawakami T; Kawanabe T; Soma Y
Acta Derm Venereol; 2009; 89(3):325-6. PubMed ID: 19479144
[No Abstract] [Full Text] [Related]
2. Oral and cutaneous lichenoid reaction secondary to imatinib: report of two cases.
Pascual JC; Matarredona J; Miralles J; Conesa V; Borras-Blasco J
Int J Dermatol; 2006 Dec; 45(12):1471-3. PubMed ID: 17184272
[No Abstract] [Full Text] [Related]
3. Lichenoid eruption to STI 571.
Lim D; Muir J
Am J Hematol; 2002 Jun; 70(2):179. PubMed ID: 12111794
[No Abstract] [Full Text] [Related]
4. Imatinib for chronic myeloid leukaemia: a NICE mess.
Lim D; Muir J
Lancet; 2001 Dec; 358(9296):1903. PubMed ID: 11741656
[No Abstract] [Full Text] [Related]
5. Heliotrope-like eruption mimicking dermatomyositis in a patient treated with imatinib mesylate for chronic myeloid leukemia.
Kuwano Y; Asahina A; Watanabe R; Fujimoto M; Ihn H; Tamaki K
Int J Dermatol; 2006 Oct; 45(10):1249-51. PubMed ID: 17040457
[No Abstract] [Full Text] [Related]
6. Imatinib mesylate causes palmoplantar hyperkeratosis and nail dystrophy in three patients with chronic myeloid leukaemia.
Deguchi N; Kawamura T; Shimizu A; Kitamura R; Yanagi M; Shibagaki N; Matsue H; Shimada S
Br J Dermatol; 2006 Jun; 154(6):1216-8. PubMed ID: 16704666
[No Abstract] [Full Text] [Related]
7. Oral lichenoid reaction to imatinib (STI 571, Gleevec).
Lim DS; Muir J
Dermatology; 2002; 205(2):169-71. PubMed ID: 12218235
[TBL] [Abstract][Full Text] [Related]
8. Development of multiple myeloma in a patient with chronic myeloid leukemia after treatment with imatinib mesylate.
Garipidou V; Vakalopoulou S; Tziomalos K
Oncologist; 2005; 10(6):457-8. PubMed ID: 15967839
[No Abstract] [Full Text] [Related]
9. Imatinib-associated lichenoid eruption: acitretin treatment allows maintained antineoplastic effect.
Dalmau J; Peramiquel L; Puig L; Fernández-Figueras MT; Roé E; Alomar A
Br J Dermatol; 2006 Jun; 154(6):1213-6. PubMed ID: 16704665
[No Abstract] [Full Text] [Related]
10. Pityriasis rosea-like eruption during treatment with imatinib mesylate: description of 3 cases.
Brazzelli V; Prestinari F; Roveda E; Barbagallo T; Bellani E; Vassallo C; Orlandi E; Passamonti F; Borroni G
J Am Acad Dermatol; 2005 Nov; 53(5 Suppl 1):S240-3. PubMed ID: 16227099
[TBL] [Abstract][Full Text] [Related]
11. Imatinib-induced erythrodermia in a patient with chronic myeloid leukemia.
Oztas P; Erbasi S; Lenk N; Polat M; Han O; Artuz F; Alli N
Acta Derm Venereol; 2006; 86(2):174-5. PubMed ID: 16648930
[No Abstract] [Full Text] [Related]
12. Challenging problems in advanced malignancy: Case 3. Imatinib mesylate-induced interstitial pneumonitis.
Rosado MF; Donna E; Ahn YS
J Clin Oncol; 2003 Aug; 21(16):3171-3. PubMed ID: 12915610
[No Abstract] [Full Text] [Related]
13. Follicular acneiform eruption induced by imatinib.
Martín JM; Jordá E; Monteagudo C; Alonso V; García L; Villalón G
J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1368-70. PubMed ID: 17062082
[No Abstract] [Full Text] [Related]
14. Neutrophilic eccrine hidradenitis induced by imatinib mesylate (Gleevec) therapy.
Dib EG; Ifthikharuddin JJ; Scott GA; Partilo SR
Leuk Res; 2005 Feb; 29(2):233-4. PubMed ID: 15607374
[No Abstract] [Full Text] [Related]
15. Imatinib-induced sweet syndrome in a patient with chronic myeloid leukemia.
Ayirookuzhi SJ; Ma L; Ramshesh P; Mills G
Arch Dermatol; 2005 Mar; 141(3):368-70. PubMed ID: 15781678
[TBL] [Abstract][Full Text] [Related]
16. Adverse events after imatinib mesylate therapy.
Burton C; Azzi A; Kerridge I
N Engl J Med; 2002 Feb; 346(9):712-3. PubMed ID: 11873781
[No Abstract] [Full Text] [Related]
17. Early and tardive skin adverse events in chronic myeloid leukaemia patients treated with imatinib.
Breccia M; Carmosino I; Russo E; Morano SG; Latagliata R; Alimena G
Eur J Haematol; 2005 Feb; 74(2):121-3. PubMed ID: 15654902
[TBL] [Abstract][Full Text] [Related]
18. [Intestinal bleeding during the treatment of chronic myeloid leukemia with imatinib mesylate].
Yokote T; Akioka T; Nakayama S; Oka S; Hara S; Yamano T; Tsuji M; Hanafusa T
Rinsho Ketsueki; 2005 Sep; 46(9):1060-4. PubMed ID: 16440765
[TBL] [Abstract][Full Text] [Related]
19. STI-571 (Gleevec) in the treatment of chronic myeloid leukaemia.
Kumar L; Kumari M; Menon H
Natl Med J India; 2002; 15(5):298. PubMed ID: 12502149
[No Abstract] [Full Text] [Related]
20. Extramedullary blast crises in CML patients in complete hematological remission treated with imatinib mesylate.
Simpson E; O'Brien SG; Reilly JT
Clin Lab Haematol; 2006 Jun; 28(3):215-6. PubMed ID: 16706941
[No Abstract] [Full Text] [Related]
[Next] [New Search]
